[Featured Stock] Plasmap, the Only FDA-Certified Company... Export Flood to 45 Countries Including Australia and Saudi Arabia

[Asia Economy Reporter Hyungsoo Park] The stock price of Plasmap, a bio plasma deep-tech company, is showing strong performance. The news that it has signed a supply contract worth approximately 20 billion KRW for its sterilizer products with Australian company TDF MEDICAL, focusing on the Australian and New Zealand markets, appears to be influencing the stock price. As the only small plasma sterilizer certified by the US FDA, it is rapidly expanding regionally in the global medical device market.

As of 11:23 AM on the 16th, Plasmap is trading at 6,310 KRW, up 8.97% from the previous day.

Plasmap’s low-temperature plasma sterilizer product (STERLINK) is not only the first non-US company to receive US FDA certification but has also obtained medical device certifications in over 45 countries including Canada (HC), Australia (TGA), Brazil (ANVISA), Japan (MHOW), Russia (RZN), and Saudi Arabia (SFDA).

Through the supply contract, it is expanding into the Australian and New Zealand regions, establishing a foothold for commercialization in the Oceania market. Along with recent large-scale supply contracts, Plasmap’s cumulative order contract amount is approximately 330 billion KRW, with 16 domestic contracts (about 90 billion KRW) and 35 overseas contracts (about 240 billion KRW). The company is experiencing rapid growth in continuous supply contracts and sales, mainly in overseas markets, through product differentiation and reliability.

Plasmap is preparing a newly launched product lineup while expanding the regional reach and application fields of its low-temperature plasma sterilizer product (brand: STERLINK) and implant plasma surface treatment product (brand: ACTILINK), both of which have obtained multiple overseas medical device certifications.

Lim Yoobong, CEO of Plasmap, said, "After recently completing our KOSDAQ listing, all employees are making their best efforts for ultra-fast growth in overseas markets," adding, "We will continue to pioneer new markets to grow into a global unicorn company."

This content was produced with the assistance of AI translation services.